Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development

被引:34
作者
Baroncelli, Silvia [1 ]
Negri, Donatella R. M. [2 ]
Michelini, Zuleika [1 ]
Cara, Andrea [1 ]
机构
[1] Ist Super Sanita, Pharmacol & Therapy Viral Dis Unit, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy
[2] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
关键词
AIDS vaccine; cynomolgus; macaque; nonhuman animal model; pigtail; rhesus; SHIV; SIV;
D O I
10.1586/14760584.7.9.1419
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past 20 years, many efforts have been made to develop a vaccine against AIDS. The lack of an animal model that can be productively infected with HIV-1 has been partially replaced by macaque species infected with SIV or chimeric SHIV. Natural SIV and chimeric SHIV cause an infection resembling human AIDS, and Asian monkeys of genus Macaca (species mulatta, fascicularis and nemestrina) should be considered a useful surrogate in vaccine trials. A multitude of vaccines and immunization approaches have been evaluated, including live-attenuated viruses, DNA vaccines, subunit proteins and viral and bacterial vectors. The results of all these studies are often difficult to interpret due to lack of standardizations, choice of challenging virus and differences in the macaque species used. This article aims at summarizing the main characteristics of the three macaque species used in vaccine trials.
引用
收藏
页码:1419 / 1434
页数:16
相关论文
共 238 条
[81]   PHYLOGENY AND NATURAL-HISTORY OF THE PRIMATE LENTIVIRUSES, SIV AND HIV [J].
HIRSCH, V ;
DAPOLITO, G ;
GOEKEN, R ;
CAMPBELL, BJ .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (06) :798-806
[82]   PATHOGENIC DIVERSITY OF SIMIAN IMMUNODEFICIENCY VIRUSES [J].
HIRSCH, VM ;
JOHNSON, PR .
VIRUS RESEARCH, 1994, 32 (02) :183-203
[83]   INDUCTION OF AIDS BY SIMIAN IMMUNODEFICIENCY VIRUS FROM AN AFRICAN-GREEN MONKEY - SPECIES-SPECIFIC VARIATION IN PATHOGENICITY CORRELATES WITH THE EXTENT OF IN-VIVO REPLICATION [J].
HIRSCH, VM ;
DAPOLITO, G ;
JOHNSON, PR ;
ELKINS, WR ;
LONDON, WT ;
MONTALI, RJ ;
GOLDSTEIN, S ;
BROWN, C .
JOURNAL OF VIROLOGY, 1995, 69 (02) :955-967
[84]   AN AFRICAN PRIMATE LENTIVIRUS (SIVSM) CLOSELY RELATED TO HIV-2 [J].
HIRSCH, VM ;
OLMSTED, RA ;
MURPHEYCORB, M ;
PURCELL, RH ;
JOHNSON, PR .
NATURE, 1989, 339 (6223) :389-392
[85]   Characterization of a maternal-fetal HIV transmission model using pregnant macaques infected with HIV-2287 [J].
Ho, RJY ;
Larsen, K ;
Kinman, L ;
Sherbert, C ;
Wang, XY ;
Finn, E ;
Nosbisch, C ;
Schmidt, A ;
Anderson, D ;
Hu, SL ;
Agy, M ;
Ochs, H ;
Morton, WR ;
Unadkat, JD .
JOURNAL OF MEDICAL PRIMATOLOGY, 2001, 30 (03) :131-140
[86]   Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239 [J].
Horton, H ;
Vogel, TU ;
Carter, DK ;
Vielhuber, K ;
Fuller, DH ;
Shipley, T ;
Fuller, JT ;
Kunstman, KJ ;
Sutter, G ;
Montefiori, DC ;
Erfle, V ;
Desrosiers, RC ;
Wilson, N ;
Picker, LJ ;
Wolinsky, SM ;
Wang, CX ;
Allison, DB ;
Watkins, DI .
JOURNAL OF VIROLOGY, 2002, 76 (14) :7187-7202
[87]   A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques [J].
Hsu, M ;
Ho, SH ;
Balfe, P ;
Gettie, A ;
Harouse, J ;
Blanchard, J ;
Cheng-Mayer, C .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (04) :383-387
[88]   Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVSF162P3 gp120 variants [J].
Hsu, M ;
Buckner, C ;
Harouse, J ;
Gettie, A ;
Blanchard, J ;
Robinson, JE ;
Chen-Mayer, C .
JOURNAL OF MEDICAL PRIMATOLOGY, 2003, 32 (4-5) :211-217
[89]  
Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508
[90]   Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes [J].
Igarashi, T ;
Endo, Y ;
Nishimura, Y ;
Buckler, C ;
Sadjadpour, R ;
Donau, OK ;
Dumaurier, MJ ;
Plishka, RJ ;
Buckler-White, A ;
Martin, MA .
JOURNAL OF VIROLOGY, 2003, 77 (20) :10829-10840